Risk Factor Questionnaire for Young Onset Colorectal Cancer

This trial focuses on young onset colorectal cancer, affecting individuals diagnosed before age 50. Researchers aim to gather information to compare this type of cancer with cases diagnosed later in life. The study collects data and stool samples from two groups: those diagnosed with colorectal cancer before age 50 and those diagnosed at age 50 or older. Ideal participants are individuals newly diagnosed with colorectal cancer who have not yet undergone treatment.

As an unphased trial, this study offers participants the chance to contribute to valuable research that could enhance understanding and treatment of colorectal cancer in younger patients.

Researchers are excited about this trial because it aims to uncover critical insights about young onset colorectal cancer, which affects patients under 50. Unlike standard treatments that focus on chemotherapy, radiation, or surgery, this study is unique in its approach by collecting and analyzing stool samples. This method could reveal early detection markers or unique characteristics of colorectal cancer in younger patients, potentially leading to more personalized and effective treatment strategies in the future. Understanding these differences may help improve outcomes and tailor interventions specifically for this younger demographic, who often face distinct challenges compared to older patients with the same condition.